Phase separation of p53 precedes aggregation and is affected by oncogenic mutations and ligands
Elaine C. Petronilho, Murilo M. Pedrote, Mayra A. Marques, Yulli M. Passos, Michelle F. Mota, Benjamin Jakobus, Gileno dos S. de Sousa, Filipe Pereira da Costa, Adriani L. Felix, Giulia D. S. Ferretti, Fernando P. Almeida, Yraima Cordeiro, Tuane C. R. G. Vieira, Guilherme A. P. de Oliveira, Jerson L. Silva
Abstract
. Heparin apparently stabilized the condensates in a gel-like state, and RNA apparently induced a solid-like state of the protein even in the absence of PEG. Conditions that destabilize p53C into a molten globule conformation also produced liquid droplets in the absence of crowding. The disordered transactivation domain (TAD) modulated both phase separation and amyloid aggregation. In summary, our data provide mechanistic insight into the formation of p53 condensates and conditions that may result in the formation of aggregated structures, such as mutant amyloid oligomers, in cancer. The pathway of mutant p53 from liquid droplets to gel-like and solid-like (amyloid) species may be a suitable target for anticancer therapy.